Uniquity Bio Emerges from Stealth with $300M from Blackstone, Targets Asthma and COPD

Published: May 15, 2024 By Kate Goodwin

C-suite strategies

Pictured: Photo illustration of hundred dollar bill and graph/iStock, Darren415

Blackstone Life Sciences on Wednesday launched Uniquity Bio, a clinical-stage drug development company focused on immunology and inflammation, with a Phase…
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks